arrow
E

Elaine Sanij

St Vincent's Institute of Medical Research
H指数:31
被引数:4,886

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Drp1 inhibitor DRP1i2 confers cardioprotection against doxorubicin-induced cardiotoxicity

Drp1i2抑制剂可对抗多柔比星诱导的心脏毒性,从而发挥心脏保护作用

2026-08-210
OA
The RNA helicase Ddx21 controls Vegfc-driven developmental lymphangiogenesis by balancing endothelial cell ribosome biogenesis and p53 function
2021-11-0827
PREAI
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP Inhibition

CX-5461使DNA损伤修复熟练的去势抵抗性前列腺癌对PARP抑制敏感

2021-08-1916
OA
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer

RNA聚合酶I转录抑制剂CX-5461通过增强同源重组熟练的高级浆液性卵巢癌中的DNA损伤反应来与拓扑异构酶1抑制协同作用

2020-11-1130
OAAI
Reprogrammed mRNA translation drives resistance to therapeutic targeting of ribosome biogenesis

重编程的mRNA翻译驱动对核糖体生物发生的治疗靶向的抗性

2020-09-1817
OAAI
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer

CX-5461激活DNA损伤反应并证明在高级别浆液性卵巢癌中的治疗效果

2020-05-2697
OAAI
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
2019-08-2291
OAAI
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
2019-08-01129
OAAI
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
2018-09-28210
OAAI
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance

Palbociclib与BRAF和MEK抑制剂协同治疗幼稚黑色素瘤,但在BRAF抑制剂耐药性发展后没有

2018-01-0359
OAAI